Viewing Study NCT01114568


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-27 @ 8:21 PM
Study NCT ID: NCT01114568
Status: COMPLETED
Last Update Posted: 2016-03-17
First Post: 2010-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study To Estimate The Relative Bioavailability of Ertugliflozin (PF-04971729, MK-8835) in Healthy Adult Participants (MK-8835-039)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module